Salivary concentrations of hexamethylene bisacetamide (HMBA) in patients receiving 5-day continuous infusions. [electronic resource]
Producer: 19880908Description: 65-8 p. digitalISSN:- 0344-5704
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.